photo
Speaker

Jeffrey Galvin

CHIEF EXECUTIVE OFFICER, AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
Rockville, Maryland, United States
Jeff Galvin is the CEO and Founder of American Gene Technologies™ (AGT). He earned his BA degree in
Economics from Harvard in 1981 and has more than 30 years of business and entrepreneurial experience
including founder or executive positions at a variety of Silicon Valley startups. Several of his companies
were taken public and/or sold to public companies, including one in the medical-technology arena that was
sold to Varian, the leading maker of linear accelerators used in cancer therapy. Following his startup
experience, he retired to become an Angel Investor in real estate and high tech. He came out of retirement
to found and fund AGT after meeting Roscoe Brady at NIH.
Speaking In
[Available On-Demand]
AGT, has a broad viral vector delivery platform evolved over ten years of advanced development. AGT…